Literature DB >> 10953214

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.

G E Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10953214     DOI： 10.1212/wnl.55.4.606

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Encephalopathy induced by combination therapy with valproic Acid and topiramate: challenging the utility of serum ammonia measurement.

Authors:  Osric Sin; Josh Batterink
Journal:  Can J Hosp Pharm       Date:  2015 Jan-Feb

Review 2.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 3.  Comparative efficacy and tolerability of drug treatments for bipolar disorder.

Authors:  S M Strakowski; M P DelBello; C M Adler
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 4.  Topiramate: a review of its use in childhood epilepsy.

Authors:  D Ormrod; K McClellan
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.